Testing effectiveness (Phase 2)Study completedNCT01921257What this trial is testingPaediatric Safety Study in Cat-PADWho this might be right forRhinoconjunctivitis Circassia Limited 16
Testing effectiveness (Phase 2)Study completedNCT00689299What this trial is testingPhase 2 Study in Adults Sensitized to CatWho this might be right forAllergy Antigen Laboratories, Inc. 167
Testing effectiveness (Phase 2)Study completedNCT02311413What this trial is testingProspective Clinical Trial of Fel d 1 Peptide ImmunotherapyWho this might be right forCat AllergyCat Hypersensitivity National Institute of Allergy and Infectious Diseases (NIAID) 39
Post-approval studies (Phase 4)Study completedNCT00637884What this trial is testingA Single-Center, Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study Designed to Evaluate the Efficacy of Fexofenadine HCl 180 mg for Preventing and Controlling Cat Allergy SymptomsWho this might be right forCat Induced Allergic Rhinitis Sanofi 70
Not applicableUnknownNCT05656482What this trial is testingAbility of a Cat Food to Reduce Respiratory Symptoms in Cat Allergic PatientsWho this might be right forRhinitis, Allergic MASK-air SAS 50
Large-scale testing (Phase 3)Study completedNCT06602726What this trial is testingDemonstrate How Well REGN1908-1909 Works in Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Cat AllergyWho this might be right forAllergic Conjunctivitis Regeneron Pharmaceuticals 64
Not applicableEnded earlyNCT02601690What this trial is testingObservational Analysis of T Cell Responses to SPIREs for Multiple Allergens in Subjects With Allergy in North AmericaWho this might be right forAllergy Adiga Life Sciences, Inc. 199
Early research (Phase 1)Study completedNCT00718679What this trial is testingEvaluation of Safety, Tolerability, Immunogenicity and Efficacy of a Novel Method in Specific Immunotherapy in Cat Allergic Patients: a Placebo Controlled TrialWho this might be right forAllergy to Cat Dander University of Zurich 20
Testing effectiveness (Phase 2)Study completedNCT01033344What this trial is testingCat-PAD Exposure Chamber StudyWho this might be right forCat Allergy Circassia Limited 210
Large-scale testing (Phase 3)Study completedNCT01620762What this trial is testingPhase III Cat-PAD StudyWho this might be right forRhinoconjunctivitis Circassia Limited 1,408
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06069063What this trial is testingCrossover Study of Zafirlukast in Preventing Allergen-induced Signs and Symptoms in Response to Cat Dander ChallengeWho this might be right forAllergy to Cats Allergy & Asthma Medical Group & Research Center 12
Testing effectiveness (Phase 2)Looking for participantsNCT06960382What this trial is testingSafety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without AsthmaWho this might be right forAllergic RhinitisAllergic Asthma University of Zurich 36
Very early researchEnded earlyNCT01292070What this trial is testingSafety Evaluation of an Experimental Treatment, Intradermal Human Fcγ1-Fel d1 Fusion Protein (GFD), for Cat AllergyWho this might be right forCat Allergy National Institute of Allergy and Infectious Diseases (NIAID) 4
Not applicableStudy completedNCT03928561What this trial is testingEfficacy of Air Cleaners in Asthmatics Allergic to Cat in ALYATEC Environmental Exposure ChamberWho this might be right forAsthmaAllergy Alyatec 24
Not applicableStudy completedNCT05455749What this trial is testingEffect of holoBLG on Cat Allergic PatientsWho this might be right forAllergy to CatsAllergic Rhinoconjunctivitis Allergy Therapeutics 42
Early research (Phase 1)Study completedNCT01383590What this trial is testingIdentification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics AnalysisWho this might be right forCat Allergy Circassia Limited 10
Testing effectiveness (Phase 2)Study completedNCT01740024What this trial is testingBiological Potency of the Cat Epithelial Allergenic ExtractsWho this might be right forCat Allergy (Disorder) Laboratorios Leti, S.L. 35
Testing effectiveness (Phase 2)Study completedNCT00987909What this trial is testingExposure Chamber Trial With Cat ImmunotherapyWho this might be right forCat Allergy ALK-Abelló A/S 60
Not applicableLooking for participantsNCT07110311What this trial is testingImpact of Pet Cats on Nasal and Gut Microbiota in Patients With Cat Allergen AllergyWho this might be right forAllergic Rhinitis The First Affiliated Hospital with Nanjing Medical University 100
Early research (Phase 1)Study completedNCT01383603What this trial is testingIdentification of Potential Biomarkers of Peptide Immunotherapy. Part 2 - Gene Array AnalysisWho this might be right forCat Allergy Circassia Limited 10